Dr. Thomas Laughren
- Former FDA Director for the Division of Psychiatry products, where he served for 29 years.
- Dr. Laughren was responsible for overseeing the review of all psychiatric drug development activities conducted under INDs and the review of all NDA’s and supplements for new psychiatric claims.
- Prior to joining the FDA in September 1983, Dr. Laughren was affiliated with the VA Medical Center in Providence, RI, and was on the faculty of the Brown University Program in Medicine.
- He has authored and co-authored many papers and book chapters on regulatory and methodological issues pertaining to the development of psychiatric drugs, and is a frequent speaker at professional meetings on these same topics. Dr. Laughren has received numerous awards for his regulatory accomplishments.